PA
RYAAY icon

PharVision Advisers’s Ryanair RYAAY Stock Holding History

PharVision Advisers’s Portfolio RYAAY Stock Details RYAAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,976
Closed -$360K – 967
2025
Q3 		$360K Buy
+5,976
New +$364K 0.2% 129

Other funds holding RYAAY

Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
SIM
Sprucegrove Investment Management Toronto, Ontario, Canada $639M AUM 23.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PharVision Advisers's RYAAY Position: Q4 2025 in Review

PharVision Advisers sold out of Ryanair (RYAAY) in Q4 2025, closing a stake of 5,976 shares — an estimated $360K sold.

PharVision Advisers first reported a position in RYAAY in Q3 2025 and held it in 1 quarter. The position peaked at $360K in Q3 2025. 424 funds tracked by Wall St. Rank hold RYAAY as of Q4 2025.

  • PharVision Advisers reported no remaining Ryanair position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 5,976 Ryanair shares in Q4 2025, an estimated $360K.
  • PharVision Advisers first reported a position in Ryanair in Q3 2025 and held it in 1 quarter.
  • PharVision Advisers's Ryanair position peaked at $360K in Q3 2025.
  • 424 funds tracked by Wall St. Rank held Ryanair as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.